Healthcare Sector Stocks
The Healthcare sector has a total of 1057 stocks, with a combined market cap of $9.41 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 50.42.
Market Cap
9.41T
Revenue
4.66T
Profits
186.64B
PE Ratio
50.42
Profit Margin
4.00%
Dividend Yield
0.38%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | -0.13% | 2,451,810 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 645.95B | 0.85% | 5,766,429 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 451.46B | -1.03% | 3,224,863 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 366.00B | -0.80% | 8,067,848 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 352.71B | -0.53% | 2,457,153 | 450.53B |
| 6 | NVS | Novartis AG | 291.11B | -0.54% | 1,165,888 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 251.73B | -1.11% | 2,880,829 | 61.37B |
| 8 | AMGN | Amgen Inc. | 233.78B | -1.05% | 1,739,954 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 230.05B | -1.35% | 1,016,629 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 202.91B | -1.41% | 8,504,975 | 50.34B |
| 11 | ABT | Abbott Laboratories | 194.62B | 0.79% | 7,545,563 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 180.64B | -2.14% | 3,946,913 | 30.46B |
| 13 | PFE | Pfizer Inc. | 159.36B | -0.21% | 27,183,853 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.89B | 0.18% | 2,860,036 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 137.30B | -1.07% | 886,918 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 136.00B | -0.55% | 5,543,592 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 131.63B | 1.51% | 1,802,434 | 11.03B |
| 18 | SYK | Stryker Corporation | 126.84B | 2.66% | 2,227,794 | 25.84B |
| 19 | CVS | CVS Health Corporation | 119.02B | 0.15% | 3,994,224 | 412.65B |
| 20 | MDT | Medtronic plc | 116.77B | 1.40% | 6,468,869 | 36.36B |
| 21 | SNY | Sanofi | 107.40B | -0.04% | 1,358,756 | 55.89B |
| 22 | MCK | McKesson Corporation | 104.16B | 0.32% | 606,054 | 410.98B |
| 23 | GSK | GSK plc | 100.70B | 1.09% | 3,432,154 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 90.46B | -0.36% | 1,000,918 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 85.54B | -1.17% | 561,391 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.30B | -1.67% | 488,306 | 15.53B |
| 27 | CI | The Cigna Group | 73.69B | 0.44% | 1,602,419 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 67.88B | 0.36% | 17,148,786 | 21.00B |
| 29 | ARGX | argenx SE | 64.97B | -3.37% | 175,521 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.45B | 0.25% | 628,857 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 57.89B | - | 1,809,973 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 55.09B | -3.35% | 25,820,564 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.55B | -0.25% | 1,779,204 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.00B | 0.29% | 2,043,703 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.62B | 0.74% | 1,693,787 | 22.48B |
| 36 | NTRA | Natera, Inc. | 47.03B | -3.67% | 833,870 | 2.71B |
| 37 | MDLN | Medline Inc. | 46.38B | 1.82% | 5,714,078 | 29.94B |
| 38 | HUM | Humana Inc. | 46.30B | -1.81% | 746,602 | 145.68B |
| 39 | VEEV | Veeva Systems Inc. | 44.80B | -1.93% | 3,642,298 | 3.46B |
| 40 | RVMD | Revolution Medicines, Inc. | 44.56B | -6.00% | 2,006,481 | - |
| 41 | HLN | Haleon plc | 43.98B | 0.70% | 7,906,724 | 14.80B |
| 42 | IDXX | IDEXX Laboratories, Inc. | 43.72B | 1.82% | 340,987 | 4.55B |
| 43 | A | Agilent Technologies, Inc. | 43.38B | -2.44% | 2,966,271 | 7.37B |
| 44 | IQV | IQVIA Holdings Inc. | 43.08B | -0.24% | 1,842,151 | 16.98B |
| 45 | TEVA | Teva Pharmaceutical Industries Limited | 42.46B | -3.14% | 3,140,918 | 17.32B |
| 46 | ONC | BeOne Medicines AG | 41.70B | -1.55% | 341,593 | 6.13B |
| 47 | WAT | Waters Corporation | 40.74B | -1.56% | 435,145 | 4.64B |
| 48 | RPRX | Royalty Pharma plc | 34.99B | -1.73% | 1,701,654 | 2.54B |
| 49 | RMD | ResMed Inc. | 34.67B | 1.94% | 1,386,749 | 5.65B |
| 50 | ALC | Alcon Inc. | 34.64B | -0.30% | 1,177,012 | 10.86B |
| 51 | DXCM | DexCom, Inc. | 34.27B | 1.71% | 2,546,958 | 4.97B |
| 52 | ILMN | Illumina, Inc. | 32.55B | -5.31% | 1,791,899 | 4.49B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 32.40B | -1.04% | 2,002,732 | 21.27B |
| 54 | BIIB | Biogen Inc. | 32.28B | -1.35% | 517,485 | 10.03B |
| 55 | CNC | Centene Corporation | 31.99B | -0.89% | 2,527,007 | 180.30B |
| 56 | ZTS | Zoetis Inc. | 31.96B | 3.09% | 4,845,303 | 9.53B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.73B | 0.23% | 1,847,140 | 4.80B |
| 58 | MTD | Mettler-Toledo International Inc. | 28.02B | -0.63% | 202,023 | 4.13B |
| 59 | LH | Labcorp Holdings Inc. | 27.18B | -0.21% | 456,547 | 14.35B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.79B | -0.76% | 639,937 | 11.56B |
| 61 | PHG | Koninklijke Philips N.V. | 26.18B | -0.74% | 531,710 | 20.18B |
| 62 | INSM | Insmed Incorporated | 25.89B | -2.35% | 1,977,867 | 1.14B |
| 63 | BNTX | BioNTech SE | 25.64B | -8.37% | 3,072,882 | 3.03B |
| 64 | INCY | Incyte Corporation | 25.21B | -2.64% | 1,215,070 | 5.82B |
| 65 | ROIV | Roivant Sciences Ltd. | 25.07B | -7.64% | 8,764,988 | 7.53M |
| 66 | WST | West Pharmaceutical Services, Inc. | 23.75B | -2.49% | 496,405 | 3.33B |
| 67 | STE | STERIS plc | 22.79B | 0.35% | 339,463 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 22.11B | -2.36% | 266,870 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 21.67B | -4.17% | 1,821,583 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.48B | -0.35% | 519,369 | 21.81B |
| 71 | GMAB | Genmab A/S | 19.98B | -2.55% | 1,518,714 | 4.13B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 19.25B | 1.44% | 1,190,909 | 8.51B |
| 73 | VTRS | Viatris Inc. | 18.77B | -3.26% | 6,218,656 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 16.77B | -1.79% | 186,917 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.28B | -0.58% | 314,793 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.87B | -2.61% | 1,193,061 | 4.60B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.66B | -1.19% | 812,988 | 3.37B |
| 78 | SOLV | Solventum Corporation | 15.51B | 0.21% | 678,866 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.97B | -2.64% | 1,922,282 | 713.07M |
| 80 | RVTY | Revvity, Inc. | 14.37B | -0.70% | 1,576,279 | 2.91B |
| 81 | CRL | Charles River Laboratories International, Inc. | 13.92B | -1.66% | 659,870 | 4.00B |
| 82 | COO | The Cooper Companies, Inc. | 13.88B | 0.30% | 1,011,291 | 4.23B |
| 83 | BAX | Baxter International Inc. | 13.51B | 0.81% | 3,960,470 | 11.47B |
| 84 | EXEL | Exelixis, Inc. | 13.49B | -1.47% | 1,486,617 | 2.44B |
| 85 | ICLR | ICON Public Limited Company | 13.12B | 0.18% | 314,631 | 8.29B |
| 86 | PEN | Penumbra, Inc. | 12.67B | 0.21% | 234,127 | 1.50B |
| 87 | BMRN | BioMarin Pharmaceutical Inc. | 12.52B | -0.96% | 1,098,427 | 3.41B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.33B | -1.83% | 268,664 | 1.28B |
| 89 | BTSG | BrightSpring Health Services, Inc. | 12.32B | -2.91% | 1,506,364 | 14.37B |
| 90 | CORT | Corcept Therapeutics Incorporated | 12.31B | -2.61% | 917,931 | 830.81M |
| 91 | FMS | Fresenius Medical Care AG | 12.28B | -0.73% | 715,626 | 22.19B |
| 92 | SNN | Smith & Nephew plc | 12.12B | -0.55% | 1,488,336 | 6.30B |
| 93 | ELAN | Elanco Animal Health Incorporated | 12.05B | -1.55% | 4,165,479 | 5.02B |
| 94 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.99B | -4.15% | 1,282,278 | 669.50M |
| 95 | HALO | Halozyme Therapeutics, Inc. | 11.96B | -1.47% | 1,681,929 | 1.66B |
| 96 | EHC | Encompass Health Corporation | 11.92B | 1.07% | 887,893 | 6.21B |
| 97 | TEM | Tempus AI, Inc. | 11.56B | -9.41% | 8,774,758 | 1.43B |
| 98 | DVA | DaVita Inc. | 11.52B | 1.01% | 461,800 | 14.01B |
| 99 | TECH | Bio-Techne Corporation | 11.35B | -0.17% | 1,630,508 | 1.22B |
| 100 | ALGN | Align Technology, Inc. | 11.19B | -0.79% | 954,649 | 4.14B |
| 101 | GMED | Globus Medical, Inc. | 11.14B | 0.52% | 1,055,445 | 3.14B |
| 102 | SMMT | Summit Therapeutics Inc. | 10.95B | -4.19% | 3,906,883 | - |
| 103 | GKOS | Glaukos Corporation | 10.60B | -1.12% | 553,530 | 612.84M |
| 104 | ABVX | ABIVAX Société Anonyme | 10.58B | -0.83% | 926,192 | 5.67M |
| 105 | AXSM | Axsome Therapeutics, Inc. | 10.42B | -3.51% | 441,308 | 776.57M |
| 106 | MOH | Molina Healthcare, Inc. | 10.42B | 0.63% | 967,170 | 42.47B |
| 107 | KRYS | Krystal Biotech, Inc. | 10.40B | -1.68% | 143,509 | 440.48M |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.37B | -0.57% | 206,973 | 2.59B |
| 109 | RDY | Dr. Reddy's Laboratories Limited | 10.27B | 0.16% | 1,674,278 | 3.50B |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.18B | 0.01% | 733,857 | - |
| 111 | IONS | Ionis Pharmaceuticals, Inc. | 10.15B | -2.21% | 1,850,853 | 874.09M |
| 112 | UHS | Universal Health Services, Inc. | 10.12B | -0.53% | 556,223 | 18.11B |
| 113 | PODD | Insulet Corporation | 10.07B | 1.20% | 1,043,384 | 3.05B |
| 114 | CYTK | Cytokinetics, Incorporated | 10.02B | -7.46% | 4,361,525 | 67.67M |
| 115 | ENSG | The Ensign Group, Inc. | 10.00B | -0.32% | 333,226 | 5.49B |
| 116 | HSIC | Henry Schein, Inc. | 9.98B | -0.84% | 795,969 | 13.60B |
| 117 | RGEN | Repligen Corporation | 9.95B | -3.16% | 818,719 | 785.10M |
| 118 | AVTR | Avantor, Inc. | 9.86B | -0.21% | 5,301,588 | 6.56B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 9.82B | -1.73% | 415,947 | 105.00M |
| 120 | PRAX | Praxis Precision Medicines, Inc. | 9.63B | -6.28% | 282,853 | 7.46M |
| 121 | OSCR | Oscar Health, Inc. | 9.39B | 1.40% | 5,181,097 | 15.32B |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 9.34B | -3.46% | 501,248 | 281.99M |
| 123 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | -0.01% | 1,127,887 | 42.16M |
| 124 | QGEN | Qiagen N.V. | 8.92B | -1.44% | 1,376,342 | 2.10B |
| 125 | PCVX | Vaxcyte, Inc. | 8.90B | -2.17% | 760,160 | - |
| 126 | TWST | Twist Bioscience Corporation | 8.87B | -7.66% | 1,380,553 | 431.80M |
| 127 | BRKR | Bruker Corporation | 8.70B | -3.66% | 1,928,404 | 3.50B |
| 128 | IBRX | ImmunityBio, Inc. | 8.53B | -4.17% | 7,980,048 | 165.79M |
| 129 | IMVT | Immunovant, Inc. | 8.51B | -5.98% | 1,082,547 | - |
| 130 | ATR | AptarGroup, Inc. | 8.46B | 0.10% | 325,434 | 3.93B |
| 131 | TXG | 10x Genomics, Inc. | 8.02B | -5.10% | 2,361,222 | 616.91M |
| 132 | HQY | HealthEquity, Inc. | 7.97B | 3.19% | 2,259,571 | 1.36B |
| 133 | SYRE | Spyre Therapeutics, Inc. | 7.97B | -3.48% | 1,266,564 | - |
| 134 | ALKS | Alkermes plc | 7.95B | -3.05% | 1,429,293 | 1.67B |
| 135 | TGTX | TG Therapeutics, Inc. | 7.65B | -3.21% | 1,030,762 | 799.54M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.38B | -4.76% | 441,209 | 239.92M |
| 137 | CAI | Caris Life Sciences, Inc. | 7.24B | -2.84% | 3,835,175 | 989.61M |
| 138 | HNGE | Hinge Health, Inc. | 7.05B | -5.92% | 2,996,632 | 720.06M |
| 139 | SRRK | Scholar Rock Holding Corporation | 7.04B | -2.46% | 809,724 | - |
| 140 | GRFS | Grifols, S.A. | 6.91B | -1.66% | 322,332 | 8.48B |
| 141 | CHE | Chemed Corporation | 6.81B | 0.60% | 150,576 | 2.60B |
| 142 | PACS | PACS Group, Inc. | 6.77B | -3.37% | 498,830 | 5.55B |
| 143 | HIMS | Hims & Hers Health, Inc. | 6.73B | -8.91% | 14,726,308 | 2.58B |
| 144 | CGON | CG Oncology, Inc. | 6.59B | -5.91% | 612,565 | 6.23M |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.58B | 0.30% | 1,143,252 | 1.56B |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.33B | -2.30% | 426,509 | 618.07M |
| 147 | ERAS | Erasca, Inc. | 6.31B | -7.49% | 2,887,576 | - |
| 148 | TVTX | Travere Therapeutics, Inc. | 6.19B | -2.74% | 808,519 | 591.33M |
| 149 | BLCO | Bausch + Lomb Corporation | 6.13B | 0.12% | 403,113 | 5.32B |
| 150 | BLTE | Belite Bio, Inc | 6.11B | -3.37% | 171,266 | - |
| 151 | AMRX | Amneal Pharmaceuticals, Inc. | 6.11B | -2.61% | 1,151,922 | 3.12B |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.09B | -2.16% | 427,301 | 840.85M |
| 153 | LQDA | Liquidia Corporation | 6.06B | -3.22% | 926,770 | 450.91M |
| 154 | ORKA | Oruka Therapeutics, Inc. | 6.03B | -5.59% | 589,442 | - |
| 155 | COGT | Cogent Biosciences, Inc. | 6.02B | -6.52% | 1,771,221 | - |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.92B | -5.11% | 376,257 | 1.90M |
| 157 | TFX | Teleflex Incorporated | 5.92B | 1.42% | 429,358 | 2.25B |
| 158 | RDNT | RadNet, Inc. | 5.87B | -1.00% | 472,842 | 2.27B |
| 159 | PTCT | PTC Therapeutics, Inc. | 5.85B | -2.40% | 692,676 | 1.01B |
| 160 | XENE | Xenon Pharmaceuticals Inc. | 5.81B | -3.13% | 587,932 | 7.50M |
| 161 | STVN | Stevanato Group S.p.A. | 5.74B | -5.70% | 344,069 | 1.40B |
| 162 | MMED | MiniMed Group, Inc. | 5.64B | 3.02% | 1,329,275 | 3.10B |
| 163 | LGND | Ligand Pharmaceuticals Incorporated | 5.59B | -1.42% | 127,696 | 290.54M |
| 164 | CRSP | CRISPR Therapeutics AG | 5.58B | -2.78% | 1,388,794 | 13.39M |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.51B | -6.48% | 1,803,237 | - |
| 166 | SHC | Sotera Health Company | 5.50B | -1.08% | 1,388,661 | 1.22B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.40B | 1.06% | 341,634 | 1.58B |
| 168 | WAY | Waystar Holding Corp. | 5.03B | 3.92% | 1,988,684 | 1.21B |
| 169 | ACAD | ACADIA Pharmaceuticals Inc. | 5.02B | -2.09% | 1,529,975 | 1.14B |
| 170 | PBLS | Parabilis Medicines, Inc. | 4.83B | -0.46% | 316,256 | 148.00K |
| 171 | DOCS | Doximity, Inc. | 4.76B | 4.45% | 3,288,957 | 655.57M |
| 172 | HAE | Haemonetics Corporation | 4.73B | -0.99% | 659,228 | 1.35B |
| 173 | LFST | LifeStance Health Group, Inc. | 4.70B | 0.08% | 4,045,647 | 1.58B |
| 174 | DYN | Dyne Therapeutics, Inc. | 4.68B | -3.91% | 1,186,931 | - |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.64B | -3.24% | 739,780 | - |
| 176 | LIVN | LivaNova PLC | 4.43B | 0.36% | 465,953 | 1.47B |
| 177 | BLLN | BillionToOne, Inc. | 4.40B | -2.01% | 423,157 | 397.41M |
| 178 | ICUI | ICU Medical, Inc. | 4.38B | - | 162,211 | 2.16B |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.37B | -1.27% | 508,131 | 2.29B |
| 180 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.36B | -6.56% | 1,361,802 | -665.00K |
| 181 | NVST | Envista Holdings Corporation | 4.36B | -1.13% | 1,210,000 | 2.86B |
| 182 | CELC | Celcuity Inc. | 4.33B | -5.15% | 610,394 | - |
| 183 | ITGR | Integer Holdings Corporation | 4.26B | 0.02% | 569,648 | 1.84B |
| 184 | ELVN | Enliven Therapeutics, Inc. | 4.24B | -4.36% | 584,982 | - |
| 185 | HTFL | HeartFlow, Inc. | 4.15B | -0.67% | 1,394,459 | 212.07M |
| 186 | INDV | Indivior Pharmaceuticals, Inc. | 4.12B | -1.22% | 3,308,672 | 1.33B |
| 187 | RLAY | Relay Therapeutics, Inc. | 4.11B | -3.35% | 2,762,934 | 10.35M |
| 188 | MANE | Veradermics, Incorporated | 4.09B | -3.81% | 623,699 | - |
| 189 | ADPT | Adaptive Biotechnologies Corporation | 4.02B | -4.73% | 1,509,096 | 308.08M |
| 190 | IRTC | iRhythm Holdings, Inc. | 3.96B | 3.37% | 439,399 | 825.34M |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.94B | -7.67% | 1,999,010 | 53.81M |
| 192 | IDYA | IDEAYA Biosciences, Inc. | 3.87B | -3.97% | 714,066 | 234.13M |
| 193 | LEGN | Legend Biotech Corporation | 3.85B | -3.02% | 1,151,200 | 1.27B |
| 194 | DNLI | Denali Therapeutics Inc. | 3.84B | -2.72% | 807,598 | 3.60M |
| 195 | TLX | Telix Pharmaceuticals Limited | 3.82B | -0.79% | 88,529 | 890.79M |
| 196 | VKTX | Viking Therapeutics, Inc. | 3.75B | -5.02% | 2,379,840 | - |
| 197 | RCUS | Arcus Biosciences, Inc. | 3.72B | -4.51% | 1,086,194 | 117.00M |
| 198 | ABCL | AbCellera Biologics Inc. | 3.68B | -8.47% | 5,861,231 | 66.17M |
| 199 | IOVA | Iovance Biotherapeutics, Inc. | 3.63B | -3.03% | 7,693,531 | 324.97M |
| 200 | OGN | Organon & Co. | 3.61B | - | 2,708,317 | 6.13B |
| 201 | OPCH | Option Care Health, Inc. | 3.58B | -0.33% | 1,195,558 | 5.69B |
| 202 | GRAL | GRAIL, Inc. | 3.57B | -3.03% | 658,514 | 165.26M |
| 203 | NHC | National HealthCare Corporation | 3.49B | 0.20% | 147,493 | 1.56B |
| 204 | VCYT | Veracyte, Inc. | 3.48B | -4.22% | 1,684,139 | 561.90M |
| 205 | PLSE | Pulse Biosciences, Inc. | 3.39B | -2.04% | 266,193 | 1.19M |
| 206 | QURE | uniQure N.V. | 3.38B | -1.69% | 843,706 | 18.67M |
| 207 | GPCR | Structure Therapeutics Inc. | 3.38B | -3.76% | 601,773 | - |
| 208 | TARS | Tarsus Pharmaceuticals, Inc. | 3.15B | -0.22% | 615,744 | 606.33M |
| 209 | IMNM | Immunome, Inc. | 3.13B | -4.50% | 784,510 | 4.02M |
| 210 | NAMS | NewAmsterdam Pharma Company N.V. | 3.10B | -3.32% | 1,036,086 | 7.12M |
| 211 | WRBY | Warby Parker Inc. | 3.09B | -1.07% | 1,606,101 | 911.61M |
| 212 | IRON | Disc Medicine, Inc. | 3.07B | -3.05% | 665,575 | - |
| 213 | CLDX | Celldex Therapeutics, Inc. | 3.07B | -3.31% | 424,938 | 158.00K |
| 214 | TMDX | TransMedics Group, Inc. | 3.07B | -3.62% | 631,158 | 668.47M |
| 215 | MBX | MBX Biosciences, Inc. | 3.03B | -5.11% | 307,655 | - |
| 216 | ARQT | Arcutis Biotherapeutics, Inc. | 2.99B | -4.38% | 1,536,019 | 463.98M |
| 217 | BEAM | Beam Therapeutics Inc. | 2.93B | -3.81% | 1,330,604 | 156.04M |
| 218 | ZLAB | Zai Lab Limited | 2.93B | -2.76% | 650,042 | 449.61M |
| 219 | AVAH | Aveanna Healthcare Holdings Inc. | 2.91B | -3.62% | 2,221,599 | 2.60B |
| 220 | ALMS | Alumis Inc. | 2.90B | -3.58% | 655,336 | 7.40M |
| 221 | ALHC | Alignment Healthcare, Inc. | 2.83B | 0.44% | 3,085,752 | 4.58B |
| 222 | BKD | Brookdale Senior Living Inc. | 2.80B | -3.06% | 5,450,210 | 2.93B |
| 223 | AXGN | Axogen, Inc. | 2.77B | -0.50% | 772,183 | 251.17M |
| 224 | RGC | Regencell Bioscience Holdings Limited | 2.73B | -0.36% | 73,414 | - |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.72B | -2.49% | 929,230 | 36.77M |
| 226 | ATAI | AtaiBeckley Inc. | 2.70B | -0.82% | 2,532,152 | 4.47M |
| 227 | SLS | SELLAS Life Sciences Group, Inc. | 2.67B | -13.15% | 9,825,411 | - |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.66B | -5.53% | 1,225,764 | 3.37B |
| 229 | PRVA | Privia Health Group, Inc. | 2.66B | -0.34% | 823,731 | 2.36B |
| 230 | VRDN | Viridian Therapeutics, Inc. | 2.61B | -3.35% | 778,882 | 71.13M |
| 231 | CDNA | CareDx, Inc. | 2.58B | -4.91% | 1,178,534 | 458.09M |
| 232 | WGS | GeneDx Holdings Corp. | 2.57B | -3.26% | 435,341 | 454.43M |
| 233 | NEOG | Neogen Corporation | 2.54B | -0.68% | 1,306,975 | 870.40M |
| 234 | SUPN | Supernus Pharmaceuticals, Inc. | 2.54B | -1.04% | 487,926 | 830.44M |
| 235 | RARE | Ultragenyx Pharmaceutical Inc. | 2.52B | -2.48% | 1,612,888 | 717.00M |
| 236 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.51B | -0.51% | 2,702,948 | 940.61M |
| 237 | PGEN | Precigen, Inc. | 2.49B | -3.34% | 2,703,251 | 85.72M |
| 238 | PBH | Prestige Consumer Healthcare Inc. | 2.49B | 2.46% | 299,807 | 1.10B |
| 239 | PHVS | Pharvaris N.V. | 2.48B | -4.54% | 479,030 | - |
| 240 | NKTR | Nektar Therapeutics | 2.48B | -2.72% | 579,716 | 54.59M |
| 241 | ATRC | AtriCure, Inc. | 2.47B | -1.48% | 390,633 | 569.62M |
| 242 | VERA | Vera Therapeutics, Inc. | 2.46B | -1.18% | 1,257,469 | - |
| 243 | TRVI | Trevi Therapeutics, Inc. | 2.39B | -6.51% | 1,972,141 | - |
| 244 | KOD | Kodiak Sciences Inc. | 2.37B | -3.58% | 469,176 | - |
| 245 | BHC | Bausch Health Companies Inc. | 2.36B | 0.32% | 1,392,005 | 10.85B |
| 246 | GRDN | Guardian Pharmacy Services, Inc. | 2.35B | -0.72% | 412,413 | 1.46B |
| 247 | RAPP | Rapport Therapeutics, Inc. | 2.34B | -4.05% | 332,731 | 20.00M |
| 248 | NUVB | Nuvation Bio Inc. | 2.34B | -4.72% | 3,663,333 | 169.90M |
| 249 | BHVN | Biohaven Ltd. | 2.33B | -4.40% | 2,888,083 | - |
| 250 | UFPT | UFP Technologies, Inc. | 2.32B | 0.03% | 102,874 | 631.64M |
| 251 | NEO | NeoGenomics, Inc. | 2.32B | -3.17% | 1,723,958 | 766.30M |
| 252 | MESO | Mesoblast Limited | 2.29B | -4.07% | 234,740 | 120.25M |
| 253 | HRMY | Harmony Biosciences Holdings, Inc. | 2.28B | -1.66% | 590,218 | 959.90M |
| 254 | TRLV | Trulieve Cannabis Corp. | 2.28B | 7.16% | 1,365,785 | 1.14B |
| 255 | OCUL | Ocular Therapeutix, Inc. | 2.28B | -4.25% | 1,563,599 | 52.06M |
| 256 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | -1.58% | 812,835 | - |
| 257 | CLOV | Clover Health Investments, Corp. | 2.25B | - | 4,178,778 | 2.48B |
| 258 | BFLY | Butterfly Network, Inc. | 2.24B | -3.33% | 3,862,936 | 112.14M |
| 259 | XRAY | DENTSPLY SIRONA Inc. | 2.22B | 0.72% | 2,971,741 | 3.64B |
| 260 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | -3.38% | 3,612,386 | 1.97B |
| 261 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | -1.15% | 630,879 | 311.51M |
| 262 | PVLA | Palvella Therapeutics, Inc. | 2.16B | -0.24% | 191,992 | - |
| 263 | NBTX | Nanobiotix S.A. | 2.13B | -8.70% | 164,856 | 38.27M |
| 264 | HCM | HUTCHMED (China) Limited | 2.13B | -0.32% | 59,142 | 549.12M |
| 265 | URGN | UroGen Pharma Ltd. | 2.13B | -4.13% | 580,051 | 188.73M |
| 266 | ALMR | Alamar Biosciences, Inc. | 2.13B | -6.94% | 267,641 | 100.42M |
| 267 | ADUS | Addus HomeCare Corporation | 2.11B | -2.08% | 191,692 | 1.48B |
| 268 | MD | Pediatrix Medical Group, Inc. | 2.11B | -0.71% | 706,848 | 1.95B |
| 269 | ESTA | Establishment Labs Holdings Inc. | 2.11B | -1.62% | 285,948 | 245.82M |
| 270 | KLRA | Kailera Therapeutics, Inc. | 2.10B | -12.52% | 532,030 | - |
| 271 | VCEL | Vericel Corporation | 2.10B | -0.56% | 491,248 | 306.30M |
| 272 | COAG | Hemab Therapeutics Holdings, Inc. | 2.09B | -9.40% | 260,079 | - |
| 273 | ADMA | ADMA Biologics, Inc. | 2.09B | -1.48% | 1,838,107 | 512.28M |
| 274 | NVCR | NovoCure Limited | 2.08B | -0.94% | 855,579 | 699.19M |
| 275 | STOK | Stoke Therapeutics, Inc. | 2.04B | -2.98% | 754,099 | 27.59M |
| 276 | ZBIO | Zenas BioPharma, Inc. | 2.04B | -4.14% | 439,142 | 1.00M |
| 277 | PRGO | Perrigo Company plc | 2.01B | 2.84% | 2,604,345 | 4.14B |
| 278 | ZYME | Zymeworks Inc. | 2.01B | -2.55% | 542,191 | 37.13M |
| 279 | PGNY | Progyny, Inc. | 1.99B | 0.54% | 832,666 | 1.31B |
| 280 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.99B | -8.24% | 5,564,528 | 208.78M |
| 281 | AGIO | Agios Pharmaceuticals, Inc. | 1.99B | -2.80% | 519,740 | 98.34M |
| 282 | GENB | Generate Biomedicines, Inc. | 1.97B | -2.79% | 2,354,945 | 26.48M |
| 283 | ASTH | Astrana Health, Inc. | 1.94B | -1.17% | 368,696 | 3.84B |
| 284 | XNCR | Xencor, Inc. | 1.94B | -9.76% | 2,051,639 | 104.97M |
| 285 | GHRS | GH Research PLC | 1.92B | -2.48% | 117,667 | - |
| 286 | CMPS | COMPASS Pathways plc | 1.90B | -6.22% | 2,646,042 | - |
| 287 | LKFT | Lakefront Biotherapeutics NV | 1.89B | -1.90% | 143,741 | 1.13B |
| 288 | IMCR | Immunocore Holdings plc | 1.89B | -0.35% | 300,327 | 430.78M |
| 289 | TSHA | Taysha Gene Therapies, Inc. | 1.88B | -3.19% | 2,070,980 | 5.49M |
| 290 | KARD | Kardigan, Inc. | 1.87B | -3.75% | 196,587 | - |
| 291 | LMAT | LeMaitre Vascular, Inc. | 1.84B | 0.98% | 217,808 | 262.43M |
| 292 | VIR | Vir Biotechnology, Inc. | 1.83B | -4.24% | 1,835,261 | 303.23M |
| 293 | PSNL | Personalis, Inc. | 1.82B | 1.61% | 2,973,181 | 69.67M |
| 294 | INBX | Inhibrx Biosciences, Inc. | 1.82B | -0.42% | 241,483 | 1.30M |
| 295 | SEPN | Septerna, Inc. | 1.82B | -3.85% | 385,882 | 98.88M |
| 296 | NTLA | Intellia Therapeutics, Inc. | 1.80B | -1.83% | 3,441,960 | 59.51M |
| 297 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | -2.91% | 10,560,576 | 54.86M |
| 298 | DMRA | Damora Therapeutics, Inc. | 1.79B | -5.23% | 371,725 | - |
| 299 | FTRE | Fortrea Holdings Inc. | 1.79B | -0.27% | 1,140,970 | 2.68B |
| 300 | BLFS | BioLife Solutions, Inc. | 1.78B | -2.20% | 1,041,880 | 106.69M |
| 301 | INSP | Inspire Medical Systems, Inc. | 1.78B | 1.02% | 517,995 | 898.74M |
| 302 | SGRY | Surgery Partners, Inc. | 1.78B | -1.72% | 2,039,009 | 3.37B |
| 303 | SNDA | Sonida Senior Living, Inc. | 1.77B | -3.95% | 597,664 | 481.07M |
| 304 | ALVO | Alvotech | 1.77B | 1.43% | 878,459 | 494.61M |
| 305 | BRVE | Braveheart Bio, Inc. | 1.76B | -1.51% | 162,457 | - |
| 306 | SNDX | Syndax Pharmaceuticals, Inc. | 1.74B | -3.08% | 1,042,619 | 252.25M |
| 307 | ETON | Eton Pharmaceuticals, Inc. | 1.71B | -4.61% | 588,746 | 105.60M |
| 308 | ANAB | AnaptysBio, Inc. | 1.67B | -1.76% | 358,569 | 232.39M |
| 309 | APMD | Apnimed, Inc. | 1.65B | 3.45% | 536,838 | 120.15M |
| 310 | AAPG | Ascentage Pharma Group International | 1.64B | -2.42% | 6,355 | 94.61M |
| 311 | FRNM | Freenome, Inc. | 1.59B | 6.10% | 1,714,328 | 35.41M |
| 312 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | -0.93% | 360,971 | 978.38M |
| 313 | AGL | agilon health, inc. | 1.55B | -1.74% | 135,630 | 5.92B |
| 314 | BCAX | Bicara Therapeutics Inc. | 1.55B | -5.64% | 524,743 | - |
| 315 | XERS | Xeris Biopharma Holdings, Inc. | 1.55B | -1.40% | 1,027,280 | 335.41M |
| 316 | ARDT | Ardent Health, Inc. | 1.55B | -0.27% | 238,287 | 6.41B |
| 317 | HCSG | Healthcare Services Group, Inc. | 1.54B | -2.18% | 632,737 | 1.86B |
| 318 | LBRX | LB Pharmaceuticals Inc | 1.54B | -0.33% | 230,559 | - |
| 319 | SLBT | SL Science Holding Limited | 1.54B | 2.27% | 41,000 | 3.27M |
| 320 | AVLN | Avalyn Pharma Inc. | 1.54B | -4.98% | 202,894 | - |
| 321 | LTGO | Latigo Biotherapeutics, Inc. | 1.53B | -3.08% | 217,742 | - |
| 322 | PAHC | Phibro Animal Health Corporation | 1.53B | 3.63% | 362,753 | 1.52B |
| 323 | NVAX | Novavax, Inc. | 1.53B | 2.32% | 4,211,771 | 413.80M |
| 324 | MAZE | Maze Therapeutics, Inc. | 1.52B | -4.06% | 250,248 | 20.00M |
| 325 | INVA | Innoviva, Inc. | 1.51B | 0.05% | 527,009 | 440.00M |
| 326 | OMCL | Omnicell, Inc. | 1.51B | -0.99% | 538,716 | 1.25B |
| 327 | KMTS | Kestra Medical Technologies, Ltd. | 1.50B | -0.66% | 151,433 | 95.13M |
| 328 | CNMD | CONMED Corporation | 1.50B | -0.68% | 216,409 | 1.37B |
| 329 | TRAX | First Tracks Biotherapeutics, Inc. | 1.50B | -6.44% | 410,018 | - |
| 330 | ABSI | Absci Corporation | 1.49B | -7.54% | 2,507,267 | 1.56M |
| 331 | TNDM | Tandem Diabetes Care, Inc. | 1.49B | 0.14% | 921,994 | 1.04B |
| 332 | TYRA | Tyra Biosciences, Inc. | 1.49B | -4.55% | 217,500 | - |
| 333 | AVBP | ArriVent BioPharma, Inc. | 1.49B | -2.68% | 353,458 | - |
| 334 | INNV | InnovAge Holding Corp. | 1.47B | -1.54% | 131,763 | 949.17M |
| 335 | SDGR | Schrödinger, Inc. | 1.47B | -3.48% | 911,650 | 259.04M |
| 336 | REPL | Replimune Group, Inc. | 1.46B | -0.64% | 2,386,776 | - |
| 337 | ATEC | Alphatec Holdings, Inc. | 1.46B | -1.36% | 1,208,748 | 815.05M |
| 338 | OMDA | Omada Health, Inc. | 1.45B | -2.39% | 1,042,266 | 309.76M |
| 339 | AZTA | Azenta, Inc. | 1.44B | -1.96% | 659,508 | 613.81M |
| 340 | ENOV | Enovis Corporation | 1.44B | 0.28% | 419,872 | 2.30B |
| 341 | AKTS | Aktis Oncology, Inc. | 1.43B | -1.53% | 314,652 | 10.06M |
| 342 | HROW | Harrow, Inc. | 1.40B | -3.30% | 401,078 | 275.59M |
| 343 | CGEM | Cullinan Therapeutics, Inc. | 1.40B | -3.98% | 630,089 | - |
| 344 | ANRO | Alto Neuroscience, Inc. | 1.38B | -3.22% | 246,759 | - |
| 345 | ORIC | ORIC Pharmaceuticals, Inc. | 1.37B | -3.64% | 765,429 | - |
| 346 | DRTS | Alpha Tau Medical Ltd. | 1.35B | -1.15% | 475,311 | - |
| 347 | OMER | Omeros Corporation | 1.35B | -3.32% | 1,144,033 | 38.42M |
| 348 | AMN | AMN Healthcare Services, Inc. | 1.34B | -1.31% | 405,672 | 3.43B |
| 349 | VOR | Vor Biopharma Inc. | 1.34B | -3.74% | 491,052 | - |
| 350 | SVRA | Savara Inc. | 1.34B | -4.19% | 1,336,330 | - |
| 351 | MGTX | MeiraGTx Holdings plc | 1.33B | -2.26% | 914,213 | 397.50M |
| 352 | JBIO | Jade Biosciences, Inc. | 1.33B | -2.11% | 357,936 | - |
| 353 | IART | Integra LifeSciences Holdings Corporation | 1.31B | 0.24% | 776,238 | 1.65B |
| 354 | AORT | Artivion, Inc. | 1.31B | 0.37% | 466,496 | 471.47M |
| 355 | NUTX | Nutex Health Inc. | 1.30B | -2.40% | 130,326 | 846.72M |
| 356 | PNTG | The Pennant Group, Inc. | 1.30B | -1.96% | 218,007 | 1.10B |
| 357 | IMTX | Immatics N.V. | 1.29B | 0.96% | 1,094,156 | 47.65M |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.29B | -8.42% | 144,827 | - |
| 359 | MLTX | MoonLake Immunotherapeutics | 1.28B | -3.48% | 700,465 | - |
| 360 | CERT | Certara, Inc. | 1.27B | -0.71% | 2,060,382 | 421.75M |
| 361 | MNKD | MannKind Corporation | 1.27B | -2.71% | 1,990,145 | 393.63M |
| 362 | CRON | Cronos Group Inc. | 1.24B | -0.29% | 1,238,847 | 179.09M |
| 363 | GDRX | GoodRx Holdings, Inc. | 1.20B | 0.57% | 1,001,599 | 785.23M |
| 364 | PRCT | PROCEPT BioRobotics Corporation | 1.19B | 1.12% | 687,266 | 337.34M |
| 365 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -3.80% | 644,535 | - |
| 366 | TDOC | Teladoc Health, Inc. | 1.18B | 2.20% | 3,669,220 | 2.49B |
| 367 | SANA | Sana Biotechnology, Inc. | 1.18B | -3.91% | 2,143,892 | - |
| 368 | USPH | U.S. Physical Therapy, Inc. | 1.17B | -0.59% | 98,770 | 804.27M |
| 369 | ODTX | Odyssey Therapeutics, Inc. | 1.17B | -6.24% | 117,279 | 99.00K |
| 370 | BVS | Bioventus Inc. | 1.16B | 0.36% | 445,696 | 581.85M |
| 371 | GLUE | Monte Rosa Therapeutics, Inc. | 1.14B | -6.56% | 884,651 | 28.73M |
| 372 | KURA | Kura Oncology, Inc. | 1.13B | -3.95% | 1,811,826 | 77.23M |
| 373 | IRMD | IRADIMED CORPORATION | 1.11B | 0.08% | 49,727 | 86.34M |
| 374 | STAA | STAAR Surgical Company | 1.11B | -1.25% | 442,987 | 339.59M |
| 375 | LMRI | Lumexa Imaging Holdings, Inc. | 1.11B | -1.88% | 342,622 | 1.04B |
| 376 | OPK | OPKO Health, Inc. | 1.10B | -1.33% | 2,415,223 | 587.90M |
| 377 | JANX | Janux Therapeutics, Inc. | 1.10B | -3.99% | 637,809 | 24.00M |
| 378 | IVA | Inventiva S.A. | 1.10B | -3.98% | 1,124,658 | 7.94M |
| 379 | AVTX | Avalo Therapeutics, Inc. | 1.05B | -2.29% | 738,276 | 59.00K |
| 380 | SLDB | Solid Biosciences Inc. | 1.05B | -3.55% | 621,525 | - |
| 381 | PCRX | Pacira BioSciences, Inc. | 1.03B | -0.27% | 483,553 | 746.16M |
| 382 | CSTL | Castle Biosciences, Inc. | 1.02B | -2.22% | 372,591 | 357.28M |
| 383 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | -1.29% | 2,679,263 | 41.47M |
| 384 | QDEL | QuidelOrtho Corporation | 1.01B | -3.79% | 1,207,889 | 2.67B |
| 385 | ABUS | Arbutus Biopharma Corporation | 1.00B | -1.93% | 4,768,968 | 181.72M |
| 386 | CADL | Candel Therapeutics, Inc. | 1.00B | -4.95% | 1,236,463 | - |
| 387 | IMMX | Immix Biopharma, Inc. | 997.26M | -2.59% | 1,143,439 | - |
| 388 | WVE | Wave Life Sciences, Inc. | 993.12M | -2.33% | 2,250,711 | 65.37M |
| 389 | GMRS | GMR Solutions Inc. | 979.29M | 0.24% | 261,431 | 5.88B |
| 390 | GERN | Geron Corporation | 970.13M | -1.31% | 7,416,983 | 204.56M |
| 391 | ARDX | Ardelyx, Inc. | 949.40M | -0.26% | 5,133,520 | 450.89M |
| 392 | DSGN | Design Therapeutics, Inc. | 945.61M | -0.92% | 820,755 | - |
| 393 | ANNX | Annexon, Inc. | 942.21M | -5.33% | 1,618,594 | - |
| 394 | AMPH | Amphastar Pharmaceuticals, Inc. | 936.26M | 0.59% | 224,533 | 730.02M |
| 395 | GLAS | Glass House Brands Inc. | 931.12M | 1.02% | 707,584 | 176.98M |
| 396 | CBLL | CeriBell, Inc. | 910.71M | 1.54% | 245,943 | 101.96M |
| 397 | OLMA | Olema Pharmaceuticals, Inc. | 898.60M | -4.82% | 740,849 | - |
| 398 | ATTO | Attovia Therapeutics, Inc. | 890.70M | -3.54% | 127,606 | 1.35M |
| 399 | ANL | Adlai Nortye Group Ltd. | 889.98M | -3.49% | 165,029 | 18.06M |
| 400 | HELP | Cybin Inc. | 889.87M | -8.01% | 1,455,254 | - |
| 401 | BBNX | Beta Bionics, Inc. | 887.20M | 0.92% | 992,747 | 119.01M |
| 402 | TBPH | Theravance Biopharma, Inc. | 885.21M | 0.06% | 414,568 | 104.31M |
| 403 | ACRS | Aclaris Therapeutics, Inc. | 884.67M | -2.44% | 1,220,841 | 8.22M |
| 404 | SGP | SpyGlass Pharma, Inc. | 883.70M | -1.89% | 89,782 | - |
| 405 | FTH | Faeth Therapeutics, Inc. | 874.44M | 0.30% | 288,296 | - |
| 406 | RIGL | Rigel Pharmaceuticals, Inc. | 868.24M | -0.81% | 246,125 | 276.79M |
| 407 | SIBN | SI-BONE, Inc. | 860.96M | 0.05% | 361,127 | 213.60M |
| 408 | HSTM | HealthStream, Inc. | 859.07M | 1.91% | 172,415 | 321.12M |
| 409 | INMD | InMode Ltd. | 853.59M | 0.07% | 456,671 | 374.63M |
| 410 | AVR | Anteris Technologies Global Corp. | 851.79M | -2.56% | 533,759 | 2.24M |
| 411 | CLYM | Climb Bio, Inc. | 836.85M | -3.25% | 840,930 | - |
| 412 | ACHV | Achieve Life Sciences, Inc. | 833.51M | -0.98% | 988,990 | - |
| 413 | COLL | Collegium Pharmaceutical, Inc. | 825.28M | -4.12% | 813,953 | 808.21M |
| 414 | PHAR | Pharming Group N.V. | 816.45M | -0.68% | 9,446 | 366.48M |
| 415 | DBVT | DBV Technologies S.A. | 815.25M | -6.04% | 146,148 | 5.04M |
| 416 | FDMT | 4D Molecular Therapeutics, Inc. | 810.43M | -1.61% | 1,101,308 | 92.01M |
| 417 | SLN | Silence Therapeutics plc | 808.01M | -0.22% | 539,705 | 615.00K |
| 418 | VREX | Varex Imaging Corporation | 779.74M | 0.05% | 719,985 | 865.00M |
| 419 | NVCT | Nuvectis Pharma, Inc. | 773.16M | -5.80% | 137,204 | - |
| 420 | AHCO | AdaptHealth Corp. | 772.44M | -0.17% | 1,759,261 | 3.36B |
| 421 | AURA | Aura Biosciences, Inc. | 767.42M | -3.90% | 441,403 | - |
| 422 | CBIO | Crescent Biopharma, Inc. | 759.72M | -0.06% | 149,149 | 11.88M |
| 423 | OCS | Oculis Holding AG | 753.75M | -1.77% | 221,870 | 1.45M |
| 424 | MNPR | Monopar Therapeutics Inc. | 751.02M | -1.80% | 221,551 | - |
| 425 | PHR | Phreesia, Inc. | 751.01M | 2.45% | 508,617 | 495.59M |
| 426 | AHG | Akso Health Group | 734.02M | -12.57% | 15,933 | 13.83M |
| 427 | NGNE | Neurogene Inc. | 732.02M | -3.38% | 132,796 | 925.00K |
| 428 | PHAT | Phathom Pharmaceuticals, Inc. | 729.17M | 2.68% | 894,428 | 239.66M |
| 429 | DRUG | Bright Minds Biosciences Inc. | 721.39M | -2.32% | 107,337 | - |
| 430 | STTK | Shattuck Labs, Inc. | 706.56M | -7.97% | 623,136 | 1.00M |
| 431 | OBX | Obsidian Therapeutics, Inc. | 706.22M | -4.34% | 260,571 | - |
| 432 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 700.72M | -4.79% | 195,037 | - |
| 433 | MPLT | MapLight Therapeutics, Inc. | 700.25M | 0.48% | 375,140 | - |
| 434 | CTMX | CytomX Therapeutics, Inc. | 699.46M | -6.14% | 2,173,851 | 18.30M |
| 435 | GYRE | Gyre Therapeutics, Inc. | 698.76M | -1.35% | 43,162 | 109.82M |
| 436 | ALLO | Allogene Therapeutics, Inc. | 697.89M | -3.35% | 3,824,689 | 4.64M |
| 437 | SSII | SS Innovations International, Inc. | 697.34M | 1.75% | 12,537 | 52.40M |
| 438 | TECX | Tectonic Therapeutic, Inc. | 696.35M | -2.94% | 157,792 | - |
| 439 | ASMB | Assembly Biosciences, Inc. | 693.69M | -2.10% | 250,029 | 74.85M |
| 440 | SOPH | SOPHiA GENETICS SA | 692.94M | -8.74% | 417,168 | 86.17M |
| 441 | EVO | Evotec SE | 690.62M | -3.05% | 28,221 | 819.47M |
| 442 | ZVRA | Zevra Therapeutics, Inc. | 686.77M | -2.41% | 617,862 | 136.07M |
| 443 | IRWD | Ironwood Pharmaceuticals, Inc. | 682.44M | -2.59% | 1,519,175 | 389.32M |
| 444 | CTEV | Claritev Corporation | 667.56M | 1.57% | 132,981 | 994.67M |
| 445 | MDXG | MiMedx Group, Inc. | 655.92M | -0.22% | 887,017 | 355.17M |
| 446 | SGMT | Sagimet Biosciences Inc. | 655.77M | -1.86% | 573,999 | - |
| 447 | ANGO | AngioDynamics, Inc. | 655.12M | 0.44% | 200,738 | 320.17M |
| 448 | VSTM | Verastem, Inc. | 653.87M | -2.17% | 1,084,375 | 87.53M |
| 449 | OABI | OmniAb, Inc. | 649.90M | -3.04% | 1,297,191 | 38.46M |
| 450 | AGMB | AgomAb Therapeutics NV | 648.60M | -4.84% | 252,920 | - |
| 451 | CRMD | CorMedix Inc. | 646.94M | -0.12% | 780,215 | 462.25M |
| 452 | PRME | Prime Medicine, Inc. | 642.23M | -0.82% | 2,694,443 | 4.07M |
| 453 | CTNM | Contineum Therapeutics, Inc. | 641.44M | -1.16% | 477,838 | - |
| 454 | RGNX | REGENXBIO Inc. | 637.69M | 3.09% | 1,754,144 | 174.48M |
| 455 | AQST | Aquestive Therapeutics, Inc. | 630.07M | -2.71% | 2,517,467 | 54.09M |
| 456 | STLN | Starling Oncology, Inc. | 628.82M | -2.68% | 960,697 | 587.24M |
| 457 | AUTL | Autolus Therapeutics plc | 622.82M | -0.85% | 1,436,887 | 117.39M |
| 458 | TLRY | Tilray Brands, Inc. | 622.47M | 0.44% | 3,377,149 | 915.45M |
| 459 | KIDS | OrthoPediatrics Corp. | 617.50M | 1.42% | 487,051 | 252.72M |
| 460 | VALN | Valneva SE | 615.36M | -1.98% | 22,287 | 163.30M |
| 461 | CTKB | Cytek Biosciences, Inc. | 608.32M | 1.30% | 796,312 | 206.71M |
| 462 | ALT | Altimmune, Inc. | 604.95M | -4.01% | 3,193,611 | 31.00K |
| 463 | ARVN | Arvinas, Inc. | 600.25M | -0.65% | 600,338 | 316.70M |
| 464 | BLSM | BlossomHill Therapeutics, Inc. | 599.39M | -1.21% | 163,562 | - |
| 465 | EIKN | Eikon Therapeutics, Inc. | 594.73M | -4.69% | 239,637 | - |
| 466 | EOLS | Evolus, Inc. | 586.53M | - | 1,059,313 | 316.49M |
| 467 | SPRY | ARS Pharmaceuticals, Inc. | 585.74M | -2.32% | 1,190,271 | 116.93M |
| 468 | WEAV | Weave Communications, Inc. | 583.19M | -0.14% | 2,048,225 | 257.79M |
| 469 | BWAY | BrainsWay Ltd. | 579.92M | -0.69% | 53,373 | 60.70M |
| 470 | DCTH | Delcath Systems, Inc. | 566.98M | -0.31% | 491,082 | 95.42M |
| 471 | PRLD | Prelude Therapeutics Incorporated | 563.38M | -13.72% | 725,233 | 22.42M |
| 472 | CAPR | Capricor Therapeutics, Inc. | 557.55M | -4.67% | 5,186,466 | 11.13M |
| 473 | PROK | ProKidney Corp. | 553.25M | 0.55% | 1,128,968 | 818.00K |
| 474 | ZURA | Zura Bio Limited | 548.14M | -2.22% | 1,893,429 | - |
| 475 | OVID | Ovid Therapeutics Inc. | 546.83M | -4.44% | 1,673,901 | 1.58M |
| 476 | ARTV | Artiva Biotherapeutics, Inc. | 542.19M | -7.12% | 223,494 | 251.00K |
| 477 | FLGT | Fulgent Genetics, Inc. | 539.57M | -1.70% | 192,539 | 323.93M |
| 478 | SCTX | Scribe Therapeutics Inc. | 536.50M | -1.39% | 201,736 | 36.28M |
| 479 | CERS | Cerus Corporation | 534.04M | -2.57% | 1,683,565 | 221.55M |
| 480 | CABA | Cabaletta Bio, Inc. | 528.98M | -7.69% | 3,239,398 | - |
| 481 | SRTA | Strata Critical Medical, Inc. | 528.15M | -3.24% | 564,473 | 255.98M |
| 482 | TCMD | Tactile Systems Technology, Inc. | 524.63M | 0.22% | 304,584 | 350.31M |
| 483 | ENTX | Entera Bio Ltd. | 524.62M | -1.62% | 138,184 | 42.00K |
| 484 | EVH | Evolent Health, Inc. | 520.07M | 0.22% | 2,213,089 | 2.10B |
| 485 | KYTX | Kyverna Therapeutics, Inc. | 517.63M | -3.13% | 524,933 | - |
| 486 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 487 | NPCE | NeuroPace, Inc. | 494.61M | 1.98% | 129,421 | 106.99M |
| 488 | SENS | Senseonics Holdings, Inc. | 493.31M | -0.74% | 353,666 | 48.55M |
| 489 | EDIT | Editas Medicine, Inc. | 485.31M | -4.24% | 3,271,637 | 47.01M |
| 490 | NRC | NRC Health | 483.31M | -0.73% | 84,323 | 140.00M |
| 491 | RZLT | Rezolute, Inc. | 482.64M | -7.23% | 1,084,885 | - |
| 492 | KMDA | Kamada Ltd. | 481.43M | 0.36% | 55,081 | 191.85M |
| 493 | EVMN | Evommune, Inc. | 480.14M | -1.85% | 350,569 | 10.00M |
| 494 | PRTA | Prothena Corporation plc | 478.97M | 2.64% | 498,115 | 54.53M |
| 495 | CLPT | ClearPoint Neuro, Inc. | 474.34M | -2.45% | 467,841 | 42.28M |
| 496 | CCCC | C4 Therapeutics, Inc. | 473.65M | -6.10% | 1,828,732 | 35.04M |
| 497 | VOGX | Vogenx, Inc. | 472.64M | 0.98% | 38,210 | - |
| 498 | SGHT | Sight Sciences, Inc. | 471.00M | 1.66% | 118,821 | 83.38M |
| 499 | DNA | Ginkgo Bioworks Holdings, Inc. | 468.69M | -4.13% | 1,263,559 | 132.42M |
| 500 | PBYI | Puma Biotechnology, Inc. | 467.68M | -1.95% | 235,040 | 231.24M |